Prostheal Vegetable Capsule
Natural health product licensed in Canada
- Licence holder
- Absorb Science Inc.
- NPN or DIN-HM
- 80043513
- Status
- Active licence
- Licence date
- 11 July 2013
- Revision date
- Not provided
- Form
- Capsule végétale
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Contains tea (Camellia sinensis). Green tea extracts must provide less than 800 mg of epigallocatechin-3-gallate per daily portion, with mandatory warnings.
annexe III, partie B (règlement (UE) 2022/2340). Regulation (EC) No 1925/2006, latest consolidated version, retrieved 21 October 2026.
- Conditions légales
Camellia sinensis (L.) Kuntze: Seules sont admises la poudre issue du broyage des feuilles et les préparations obtenues à partir des solvants suivants : l'eau, l'alcool à 25 % (v/v), ainsi que les solvants autorisés pour la décaféination ou la suppression des matières irritantes et amères. Les recommandations d'emploi ne doivent pas conduire à une ingestion quotidienne d'EGCG supérieure à 300 mg. L'étiquetage doit comporter des avertissements déconseillant leur prise en dehors des repas, ainsi que leur consommation par les enfants, les adolescents, les femmes enceintes ou allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Serenoa repens (W.Bartram) Small: L'étiquetage doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Trans-resvératrol Source : Polygonum cuspidatum - racine | 25 mg | Not calculated |
| Piper nigrum Source : Fruit Extraction ratio : 20:1 Dry plant equivalent : 24 mg | 1.2 mg | Not calculated |
| Camellia sinensis Source : Feuille Potency : 50 % EGCG | Not specified | Not calculated |
| Camellia sinensis Source : Feuille Potency : 0 <2 % Caffeine | Not specified | Not calculated |
| Camellia sinensis Source : Feuille Potency : 95 % Polyphenols | 150 mg | Not calculated |
| Serenoa repens Source : Saw Palmetto Fruit Equivalent 5:1 Extraction ratio : 5:1 Dry plant equivalent : 800 mg Potency : 45 % Fatty acid | 160 mg | Not calculated |
| Lycopersicon esculentum Source : Chair (fruit) Potency : 2 % Lycopene | 100 mg | Not calculated |
| Curcuma longa Source : Rhizome Extraction ratio : 18:1 Dry plant equivalent : 1,350 mg | 75 mg | Not calculated |
Non-medicinal ingredients
Eau, Hydroxypropyl methylcellulose, Cellulose microcristalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes de sexe masculin | minimum: 19 years | 1 Capsule | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Used in Herbal Medicine to help reduce difficulty in urination associated with the early stages of benign prostatic hyperplasia.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80043513
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.